Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TUCATINIB vs UBLITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TUCATINIB vs UBLITUXIMAB: Safety Overview

Metric TUCATINIB UBLITUXIMAB
Total FAERS Reports 6,042 1,582
Deaths Reported 640 27
Death Rate 10.6% 1.7%
Hospitalizations 1,717 213
Average Patient Age 57.6 yrs 49.7 yrs
% Female Patients 95.5% 73.4%
FDA Approval Date Apr 17, 2020 N/A
Manufacturer SEAGEN INC. TG Therapeutics, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A